The research reported showed that: the stability of cell-free HVT vaccine, lyophilized and sealed under vacuum, is very high: after one year at 4 degrees -6 degrees C and after 10 days at 37 degrees C the titre decreased only about 0.4 log(10)', the stability of the vaccine, when reconstituted for use in the diluent (sucrose-phosphate buffer), is high (80%) for at least 2 hours; the degree of protection, found in 3 tests, was about 90% with an inoculum of 20 to 100 pfu, and the PD50 was 4.9 pfu of virus per chick.
No takes yet. Share an insight, caveat, or question.
Zanella et al. (1974) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: